LA JOLLA, Calif. (Business Wire) -- Burnham Institute for Medical Research (Burnham) has announced that Karin Eastham, Executive Vice President and Chief Operating Officer and a member of the Board of Trustees has resigned effective September 30.
"Karin has made significant contributions to the Institute leading our administrative support team over the past four years. She was instrumental in establishing the relationship with our Florida partners and creating our bicoastal operation," stated John Reed, President and CEO. "We wish Karin continued success as she pursues new challenges and opportunities."
About Burnham Institute for Medical Research
Burnham Institute for Medical Research is dedicated to revealing the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Burnham is one of the fastest growing research institutes in the country with operations in California and Florida. The Institute ranks among the top four institutions nationally for NIH grant funding and among the top 25 organizations worldwide for its research impact. Burnham utilizes a unique, collaborative approach to medical research and has established major research programs in cancer, neurodegeneration, diabetes, infectious and inflammatory and childhood diseases. The Institute is known for its world-class capabilities in stem cell research and drug discovery technologies. Burnham is a nonprofit, public benefit corporation. For more information, please visit www.burnham.org.
Burnham Institute for Medical Research
Andrea Moser
Vice President, Communications
858-646-3146
amoser@burnham.org
© Business Wire
